grade
pharmaceutical primary standard
API family
naphazoline
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
SMILES string
Cl.C1CN=C(Cc2cccc3ccccc23)N1
InChI
1S/C14H14N2.ClH/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14;/h1-7H,8-10H2,(H,15,16);1H
InChI key
DJDFFEBSKJCGHC-UHFFFAOYSA-N
Gene Information
human ... ADRA1A(148), ADRA1B(147), ADRA1D(146), ADRA2A(150), ADRA2B(151), ADRA2C(152)
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Naphazoline hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Naphazoline Hydrochloride and Pheniramine Maleate Ophthalmic Solution
- Naphazoline Hydrochloride Nasal Solution
- Naphazoline Hydrochloride Ophthalmic Solution
Biochem/physiol Actions
α-肾上腺素受体激动剂；咪唑啉受体激动剂；血管收缩剂。
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
Still not finding the right product?
Explore all of our products under 萘甲唑林 盐酸盐
存储类别
11 - Combustible Solids
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 1457006-200MG | 04061838736321 |